Managers / Q3 2020 · view latest →
DUDLEY & SHANLEY, INC.
CIK 0000883511 · 205 WORTH AVENUE, #311, PALM BEACH, FL, 33480 · 5618554742
Summary
Dudley & Shanley, Inc. reported $412M in U.S.-listed holdings across 30 positions for Q3 2020.
Its largest position, WPM, represents 12.9% of the portfolio.
Compared with Q2 2020, the fund opened 7 new positions and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 89.6% · $369M
- Other · 10.0% · $41M
- ETP · 0.4% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| HNMOrmat Technologies | NEW | +212.1K | 212.1K | +$13M | $13M |
| AVTRAvantor Inc. | NEW | +248.5K | 248.5K | +$6M | $6M |
| ProShares USH SP500 | NEW | +284.0K | 284.0K | +$2M | $2M |
| Vanguard SP500 ETF | NEW | +2.1K | 2.1K | +$657,000 | $657,000 |
| IShares CORE SP500 | NEW | +1.9K | 1.9K | +$636,000 | $636,000 |
| T7DTransDigm Group Inc. | NEW | +1.0K | 1.0K | +$475,000 | $475,000 |
| IShares Edge Qlt ETF | NEW | +4.0K | 4.0K | +$416,000 | $416,000 |
| Else Nutrition Hldings | ADDED | +46.5K | 61.5K | +$89,000 | $112,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2026 | $662M | 38 | Jul 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q1 2026 | $611M | 38 | Apr 8, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $622M | 34 | Jan 9, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $622M | 33 | Oct 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $637M | 37 | Jul 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $635M | 37 | Apr 9, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $648M | 38 | Jan 3, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $582M | 37 | Jul 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $593M | 37 | Apr 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $561M | 35 | Jan 12, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $529M | 37 | Oct 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $554M | 38 | Jul 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $521M | 37 | Apr 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $444M | 34 | Jan 18, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2022 | $357M | 28 | Oct 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $446M | 34 | Jul 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $538M | 34 | Apr 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $578M | 37 | Jan 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $569M | 32 | Nov 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $606M | 32 | Jul 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $579M | 31 | Apr 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $543M | 30 | Jan 20, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $412M | 30 | Nov 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $361M | 23 | Jul 21, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $398M | 26 | Apr 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $443M | 24 | Jan 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $405M | 24 | Oct 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $414M | 26 | Jul 10, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $386M | 27 | Apr 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $400M | 31 | Jan 15, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.